• 1
    Sanchez, J. and Holmgren, J., Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell. Mol. Life Sci. 2008. 65: 13471360.
  • 2
    Mathis, D., Vence, L. and Benoist, C., Beta-cell death during progression to diabetes. Nature 2001. 414: 792798.
  • 3
    Shoda, L. K. M., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S. et al., A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005. 23: 115126.
  • 4
    Ploix, C., Bergerot, I., Durand, A., Czerkinsky, C., Holmgren, J. and Thivolet, C., Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells. Diabetes 1999. 48: 21502156.
  • 5
    Aspord, C., Czerkinsky, C., Durand, A., Stefanutti, A. and Thivolet, C., α4 integrins and L-selectin differently orchestrate T-cell activity during diabetes prevention following oral administration of CTB-insulin. J. Autoimmun. 2002. 19: 223232.
  • 6
    Gong, Z., Pan, L., Le, Y., Liu, Q., Zhou, M., Xing, W., Zhuo, R. et al., Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism. Vaccine 2010. 28: 40524058.
  • 7
    Denes, B., Krausova, V., Fodor, N., Timiryasova, T., Henderson, D., Hough, J., Yu, J. et al., Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens. J. Immunother. 2005. 28: 438448.
  • 8
    Bregenholt, S., Wang, M., Wolfe, T., Hughes, A., Bærentzen, L., Dyrberg, T., Von Herrath, M. G. et al., The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand. J. Immunol. 2003. 57: 432438.
  • 9
    Bergerot, I., Ploix, C., Petersen, J., Moulin, V., Rask, C., Fabien, N., Lindblad, M. et al., A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmuneÄâdiabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 46104614.
  • 10
    Gong, Z., Jin, Y. and Zhang, Y., Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunitÄìinsulin B chain fusion protein vaccine produced in silkworm. Vaccine 2007. 25: 14441451.
  • 11
    Arakawa, T., Yu, J., Chong, D. K. X., Hough, J., Engen, P. C. and Langridge, W. H. R., A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 1998. 16: 934938.
  • 12
    Achenbach, P., Barker, J. and Bonifacio, E., Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization. Curr. Diabetes Rep. 2008. 8: 8793.
  • 13
    Sánchez, j. and Holmgren, J., Cholera toxin – a foe & a friend. Indian J. Med. Res. 2011. 133: 153163.
  • 14
    Haskins, K. and McDuffie, M., Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990. 249: 14331436.
  • 15
    Stratmann, T., Martin-Orozco, N., Mallet-Designe, V., Poirot, L., McGavern, D., Losyev, G., Dobbs, C. M. et al., Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 2003. 112: 902914.
  • 16
    Yoshida, K., Martin, T., Yamamoto, K., Dobbs, C., Munz, C., Kamikawaji, N., Nakano, N. et al., Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int. Immunol. 2002. 14: 14391447.
  • 17
    Rivas, E. I., Driver, J. P., Garabatos, N., Presa, M., Mora, C., Rodriguez, F., Serreze, D. V. et al., Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse. J. Immunol. 2011. 186: 40784087.
  • 18
    Tinker, J. K., Erbe, J. L. and Holmes, R. K., Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation system. Infect. Immun. 2005. 73: 36273635.
  • 19
    Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L., Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992. 89: 421425.
  • 20
    Melamed, D. and Friedman, A., Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 1993. 23: 935942.
  • 21
    Hadis, U., Wahl, B., Schulz, O., Hardtke-Wolenski, M., Schippers, A., Wagner, N., Muller, W. et al., Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011. 34: 237246.
  • 22
    Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J. and Curotto de Lafaille, M. A., Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 2005. 115: 19231933.
  • 23
    Prochazka, M., Serreze, D. V., Frankel, W. N. and Leiter, E. H., NOR/Lt Mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 1992. 41: 98106.
  • 24
    D'Alise, A. M., Auyeung, V., Feuerer, M., Nishio, J., Fontenot, J., Benoist, C. and Mathis, D., The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 2008. 105: 1985719862.
  • 25
    Masteller, E. L., Warner, M. R., Ferlin, W., Judkowski, V., Wilson, D., Glaichenhaus, N. and Bluestone, J. A., Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 2003. 171: 55875595.
  • 26
    Grdic, D., Ekman, L., SchÖn, K., Lindgren, K., Mattsson, J., Magnusson, K.-E., Ricciardi-Castagnoli, P. et al., Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J. Immunol. 2005. 175: 51925202.
  • 27
    Tarkowski, A., Sun, J.-B., Holmdahl, R., Holmgren, J. and Czerkinsky, C., Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen–cholera toxoid conjugate vaccine. Arthritis Rheum. 1999. 42: 16281634.
  • 28
    Broere, F., Wieten, L., Klein Koerkamp, E. I., van Roon, J. A. G., Guichelaar, T., Lafeber, F. P. and van Eden, W., Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes. J. Immunol. 2008. 181: 899906.
  • 29
    Fukaya, T., Takagi, H., Sato, Y., Sato, K., Eizumi, K., Taya, H., Shin, T. et al., Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3 +regulatory T cells in the establishment of oral tolerance. Blood 2010. 116: 22662276.
  • 30
    Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 12371240.
  • 31
    Ise, W., Nakamura, K., Shimizu, N., Goto, H., Fujimoto, K., Kaminogawa, S. and Hachimura, S., Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation. J. Immunol. 2005. 175: 829838.
  • 32
    Mirenda, V., Millington, O., Lechler, R. I., Scott, D., Hernandez-Fuentes, M. P., Read, J., Tan, P. H. et al., Tolerant Tcells display impaired trafficking ability. Eur. J. Immunol. 2005. 35: 21462156.
  • 33
    Poulin, M. and Haskins, K., Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J. Immunol. 2000. 164: 30723078.
  • 34
    Koarada, S., Wu, Y. and Ridgway, W. M., Increased entry into the IFN-γ effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background. J. Immunol. 2001. 167: 16931702.
  • 35
    Quinn, A., McInerney, B., Reich, E. P., Kim, O., Jensen, K. P. and Sercarz, E. E., Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J. Immunol. 2001. 166: 29822991.
  • 36
    Haribhai, D., Lin, W., Relland, L. M., Truong, N., Williams, C. B. and Chatila, T. A., Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 2007. 178: 29612972.
  • 37
    Chao, C.-C. and McDevitt, H. O., Identification of immunogenic epitopes of GAD 65 presented by AÄä g7 in non-obese diabetic mice. Immunogenetics 1997. 46: 2934.
  • 38
    Paula de Mattos Arêas, A., Leonor Sarno de Oliveira, M., Raul Romero Ramos, C., Sbrogio-Almeida, M. E., Raw, I. and Ho, P. L., Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. Protein Expr. Purif. 2002. 25: 481487.
  • 39
    Stratmann, T., Apostolopoulos, V., Mallet-Designe, V., Corper, A. L., Scott, C. A., Wilson, I. A., Kang, A. S. et al., The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 2000. 165: 32143225.
  • 40
    Corper, A. L., Stratmann, T., Apostolopoulos, V., Scott, C. A., Garcia, K. C., Kang, A. S., Wilson, I. A. et al., A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000. 288: 505511.
  • 41
    Panus, J. F., McHeyzer-Williams, L. J. and McHeyzer-Williams, M. G., Antigen-specific T helper cell function: differential cytokine expression in primary and memory responses. J. Exp. Med. 2000. 192: 13011316.